Purulent Vaginal Discharge

What is Purulent Vaginal Discharge?

Purulent vaginal discharge is a thick, cloudy, yellow‑ or green‑tinged fluid that comes from the vagina. The term “purulent” means the discharge contains pus, which is a mixture of dead white blood cells, bacteria, and tissue debris. In most cases the discharge is a sign that the body is trying to fight an infection, but it can also result from non‑infectious inflammation.

Although a small amount of normal vaginal secretions varies throughout the menstrual cycle, purulent discharge is usually abnormal and warrants evaluation, especially if it is accompanied by other symptoms such as odor, itching, or pain.

Common Causes

Many different conditions can produce a purulent‑looking discharge. Below are the most frequently encountered causes in women of reproductive age and beyond:

• Bacterial Vaginosis (BV) – An overgrowth of anaerobic bacteria that creates a thin, gray‑white discharge with a “fishy” odor. In some women the discharge may appear more yellow or purulent.
• Trichomoniasis – A sexually transmitted infection (STI) caused by the protozoan Trichomonas vaginalis. The discharge is often thick, frothy, yellow‑green, and malodorous.
• Gonorrhea – Neisseria gonorrhoeae infection of the cervix or urethra frequently produces a purulent, sometimes blood‑tinged discharge.
• Chlamydia – Although chlamydial cervicitis more often causes a watery or mucoid discharge, mixed infections can result in a purulent appearance.
• Pelvic Inflammatory Disease (PID) – Ascending infection of the upper genital tract (uterus, fallopian tubes, ovaries). PID can cause a foul‑smelling, purulent vaginal discharge that may be continuous or intermittent.
• Candidiasis (Yeast Infection) – Typically produces a thick, white “cottage‑cheese” discharge, but severe or mixed infections can become yellowish and purulent.
• Urinary Tract Infection (UTI) with Vaginal Involvement – In women with anatomical proximity, a bladder infection can cause irritation and a secondary purulent discharge.
• Foreign Body or Retained Tampon – A forgotten tampon or contraceptive device can create a local infection that leads to foul, purulent discharge.
• Atrophic Vaginitis (post‑menopausal) – Thinning of the vaginal lining can become secondarily infected, producing a yellowish discharge.
• Neoplastic Lesions – Rarely, cervical, vaginal, or uterine cancers can ulcerate and secrete purulent material.

Associated Symptoms

The presence of purulent discharge often coincides with other clinical findings. Commonly reported accompanying symptoms include:

• Vaginal itching or burning
• Odor that ranges from mild to strong “fishy” or foul
• Pelvic or lower abdominal pain, especially during intercourse or urination
• Bleeding between periods, after sex, or after a bowel movement
• Fever, chills, or generalized malaise (more common with PID or severe infection)
• Urinary urgency, dysuria, or frequency
• Swollen, tender labia or perineal skin

When to See a Doctor

Because purulent discharge can be a sign of a sexually transmitted infection or an ascending pelvic infection, prompt medical attention is important. Seek care if you notice any of the following:

• Discharge that is yellow, green, or gray and has a strong odor
• Accompanying pelvic pain, pain during sex, or painful urination
• Fever ≥ 100.4 °F (38 °C) or chills
• Bleeding that is unexpected (between periods, after intercourse, or post‑menopausal)
• Sudden worsening of symptoms after previously mild discharge
• Pregnancy or suspicion of pregnancy (any abnormal discharge during pregnancy needs evaluation)

Diagnosis

Healthcare providers use a combination of history, physical examination, and laboratory testing to determine the cause.

History & Physical Exam

• Detailed sexual, menstrual, and contraceptive history
• Review of recent antibiotic use, douching, or tampon use
• Speculum examination to visualize the cervix and collect samples
• Palpation of the uterus and adnexa to assess for tenderness (suggests PID)

Laboratory Tests

• Wet mount microscopy – Fresh discharge examined under a microscope for clue cells (BV), motile trichomonads, yeast, or white blood cells.
• Amsel criteria – Clinical scoring system for BV (pH > 4.5, “whiff” odor, clue cells, thin discharge).
• Nucleic acid amplification tests (NAATs) – Highly sensitive for gonorrhea and chlamydia; can be performed on a vaginal swab or urine sample.
• Culture – Occasionally used for resistant gonorrhea or atypical organisms.
• Pregnancy test – Important before prescribing certain antibiotics.
• Complete blood count (CBC) and inflammatory markers – May be ordered if systemic infection or PID is suspected.

Treatment Options

Treatment is directed at the underlying cause. Empiric therapy is common when an STI is suspected, but definitive treatment follows test results.

Medical Treatments

• Antibiotics for bacterial infections
  • Gonorrhea: Ceftriaxone 500 mg IM + Azithromycin 1 g PO (single dose) – CDC 2024 recommendation.
  • Chlamydia: Doxycycline 100 mg PO twice daily for 7 days (or Azithromycin 1 g PO single dose if doxycycline contraindicated).
  • Bacterial Vaginosis: Metronidazole 500 mg PO twice daily for 7 days or a single 2 g dose; alternatively, clindamycin cream 2% intravaginally for 7 days.
  • Trichomoniasis: Metronidazole 2 g PO single dose or 500 mg PO twice daily for 7 days.
• Antifungals for candidiasis
  • Fluconazole 150 mg PO single dose (or 100 mg daily for 3 days if refractory).
  • Topical azole creams (clotrimazole, miconazole) applied 1–2 times daily for 7 days.
• Pain and inflammation control
  • Acetaminophen or ibuprofen as needed (unless contraindicated).
• Adjunctive therapy for PID – Combination of ceftriaxone + doxycycline ± metronidazole for 14 days (CDC 2024). Hospitalization may be required for severe cases.

Home & Supportive Measures

• Maintain good genital hygiene: gently wash with warm water; avoid scented soaps, douches, and vaginal deodorants.
• Wear breathable, cotton underwear and change damp clothing (e.g., after swimming or exercise) promptly.
• Complete the full course of prescribed medication even if symptoms improve early.
• Avoid sexual intercourse until treatment is finished and symptoms have resolved; use condoms to prevent reinfection.
• Probiotic supplements (Lactobacillus rhamnosus GG, L. reuteri) may help restore normal vaginal flora after antibiotic therapy, though evidence is supportive rather than definitive.

Prevention Tips

Many of the conditions that cause purulent discharge are sexually transmitted or related to disturbances in vaginal flora. Practical steps to lower risk include:

• Practice consistent and correct condom use during vaginal, oral, and anal sex.
• Limit the number of sexual partners and discuss STI testing with partners regularly.
• Undergo routine STI screening at least once a year, or more often if risk factors are present (CDC guidelines).
• Avoid intra‑vaginal douching, scented tampons, and perfumed hygiene products.
• Change menstrual products (tampons/pads) at least every 4–6 hours.
• Maintain a balanced diet rich in fermented foods (yogurt, kefir) to support healthy lactobacilli.
• Stay well‑hydrated and manage blood glucose if diabetic, as hyperglycemia predisposes to yeast overgrowth.
• For post‑menopausal women, consider low‑dose vaginal estrogen (prescribed) to improve mucosal health and reduce atrophic infections.

Emergency Warning Signs

Key Take‑aways

Purulent vaginal discharge is a red flag that usually points to an infection—most commonly bacterial vaginosis, trichomoniasis, gonorrhea, chlamydia, or a mixed vaginal infection. Prompt evaluation, appropriate laboratory testing, and targeted treatment are essential to resolve symptoms, prevent complications (like PID, infertility, or ectopic pregnancy), and reduce transmission to partners. Practicing safe sex, maintaining proper genital hygiene, and seeking timely medical care remain the cornerstones of prevention and health.

Sources: CDC 2024 Sexually Transmitted Diseases Treatment Guidelines; Mayo Clinic. “Vaginal discharge” (2023); WHO. “Reproductive health and sexually transmitted infections” (2024); Cleveland Clinic. “Bacterial Vaginosis” (2023); NIH. “Pelvic Inflammatory Disease” (2022).